M.D., Ph.D., MSPH, Physician Executive for Clinical Strategy, Cerner Corporation
Dr. John David Larkin Nolen provides clinical strategic guidance for Cerner Corporation’s solutions in precision medicine, laboratory medicine, behavioral health, and long-term post-acute care. Using his clinical knowledge, analytical skills and engineering talents, he is positioning Cerner’s solutions and clients for the future of medicine. He represents Cerner on boards, working groups, and standards organizations, including HL7, IHE, DICOM, IOM, AMIA, and CLSI. Dr. Nolen joined Cerner in 2010 as the Director of Laboratory Strategy. Since then, he has been instrumental in guiding the incorporation of new solutions around genomics, automation, and technologies into Cerner solutions. He transitioned to the Managing Director of the laboratory business unit in 2013, and expanded his clinical strategic responsibilities in 2015 to solutions beyond laboratory medicine.
The Role of Interoperability of Patient Data in Precision Medicine
The emergence of the SMART on FHIR platform has ushered in a new landscape of interoperability for healthcare IT. It is enabling precision medicine by knocking down barriers and legacy paradigms to make the healthcare IT landscape flat and let the data flow. This talk will cover the current state of the precision medicine landscape from an IT perspective and highlight where things are headed.
Session Synopsis: Our lives and our practices are quickly adapting to the impacts of new trends in mobile health. These trends are breaking down barriers and integrating virtual services within the primary care clinic, leading to advantages such as cost reduction, clinical efficacy, care for the elderly, and access to digital health data that patients and consumers can use to improve their health.